FDA Inspection 801695 — Albert W. Schreiner III
The FDA completed an inspection of Albert W. Schreiner III on September 28, 2012 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 28, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cincinnati, OH (United States)
Additional Details
Clinical Investigator (CI)